Natsume et al. [42] indicated that the level of CXCL2 in the urine of GC patients with peritoneal metastasis was significantly higher than that in those without peritoneal metastasis, and the CXCL2-VEGFA axis plays a vital role in the peritoneal metastasis of GC. This evidence concerns the gene VEGFA and gastric cancer.